Skip to main content

Advertisement

Table 2 Survival analysis of OS

From: Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

  OS
HR_U(95%CI) p value HR_M(95%CI) p value
Age at diagnosis
 <60y 1.000    
  ≥ 60y 1.393(0.549–3.535) 0.485   
Sex
 Male 1.000    
 Female 0.426(0.160–1.137) 0.088   
Primary site
 Extranodal 1.000.    
 Nodala 2.267(0.744-6.911) 0.150   
IPI risk category
 Low 1.000   1.000  
 Low-intermediate 2.029(0.545–7.559) 0.292 2.510(0.669–9.421) 0.173
 High-intermediate 3.385(0.976–11.746) 0.055 2.836(0.815–9.873) 0.101
 High 5.487(1.467–20.517) 0.011 6.986(1.845–26.450) 0.004
Treatment
 RCHOP 1.000    
 Resection & RCHOP 0.152(0.020–1.145) 0.067   
Hans Algorithm
 GCB 1.000    
 Non-GCB 1.419(0.505–3.984) 0.506   
PCDH10 Methylation
 No 1.000   1.000  
 Yes 3.547(1.166–10.791) 0.026 4.045(1.287–12.711) 0.017
MYC FISH Breakapart
 No 1.000    
 Yes 1.285(0.170–9.713) 0.808   
  1. HR_U hazard ratio by univariate analysis, HR_M hazard ratio by multivariate analysis
  2. aDLBCL arising in spleen was considered as primary nodal lymphoma [20]